Bristol Myers Squibb
This role involves designing and executing hypothesis-driven studies to develop robust, scalable manufacturing strategies for targeted lipid nanoparticle (LNP) platforms. The scientist will optimize end-to-end processes, establish mechanistic understanding, and collaborate cross-functionally to translate early process insights into development-ready drug products. The position requires expertise in process science, experimental innovation, and emerging technologies to advance non-viral delivery systems.
Headquarters
Lawrence Township, New Jersey, United States
Company Size
10001+ employees
Founded
1887
Bristol Myers Squibb is a global biopharmaceutical company that discovers, develops, and delivers prescription medicines for serious diseases, with a focus on oncology, hematology, immunology, cardiovascular, neuroscience, and other therapeutic areas. The company operates in the pharmaceutical and biotechnology industry, serving patients worldwide through research, development, manufacturing, and commercialization of innovative therapies.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Bristol Myers Squibb.
LNP Senior Scientist
ElevateBio
Associate Scientist, Non Viral Delivery Technologies (Regeneron Genetics Medicines) 2
Regeneron Pharmaceuticals
Principal Scientist, LNP Platform & Process Development (Scientist)
Tr1X
Senior Scientist / Senior Engineer, LNP Process Development
Prime Medicine
Process Engineering Co-op
Beam Therapeutics
Senior Scientist, Discovery Sciences & Technologies
Gilead Sciences